Drug prescribing for chronic medical disorders during pregnancy: an overview.
Women of reproductive age with chronic medical disorders are often concerned about hazards from drug exposure during pregnancy. The avoidance of any medication after conception may be ideal but is often unwise for maternal well-being. Adverse fetal effects are often not clinically apparent. Current standards for prescribing these medications during pregnancy are discussed from a review of the recent literature.
D001249:Asthma / Q000188:drug therapy; D002908:Chronic Disease; D003095:Collagen Diseases / Q000188:drug therapy; D004358:Drug Therapy / Q000592:standards*; D004760:Enterocolitis / Q000188:drug therapy; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011254:Pregnancy in Diabetics / Q000188:drug therapy; D012640:Seizures / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy; D013959:Thyroid Diseases / Q000188:drug therapy